Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 60.28%5.24M | 3.35M | -130K | -6.97%12.54M | 3.1M | 3.27M | 7.76%13.48M | -17.18%12.51M | 70.16%15.11M | 83.42%8.88M |
| Net profit before non-cash adjustment | 50.26%2.88M | --1.74M | --619K | -16.04%7.17M | --107.33K | --1.92M | 15.79%8.54M | -41.47%7.38M | 73.33%12.6M | 111.87%7.27M |
| Total adjustment of non-cash items | -37.54%1.04M | --1.3M | --1.52M | -0.97%5.81M | --1.49M | --1.67M | 66.63%5.87M | 15.54%3.52M | 220.33%3.05M | -56.33%950.99K |
| -Depreciation and amortization | 3.59%1.42M | --1.45M | --1.37M | 8.32%5.43M | --1.44M | --1.37M | -26.07%5.01M | 21.78%6.78M | 163.55%5.57M | 17.11%2.11M |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | -90.84%23.34K | --341 | ---- | 270.58%254.82K | -85.17%68.76K | 18.49%463.77K | 9.14%391.41K |
| -Disposal profit | -178.57%-99K | --60K | --372K | -84.22%-122.05K | --29.96K | --126K | 83.57%-66.25K | 40.09%-403.23K | 64.16%-673.1K | -586.74%-1.88M |
| -Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | 666.23%198.65K | -108.25%-35.08K | --425.03K | ---- |
| -Other non-cash items | -358.00%-387K | ---208K | ---229K | 2.61%476.83K | --19.83K | --150K | 116.07%464.72K | -5.63%-2.89M | -941.91%-2.74M | 12.71%325.15K |
| Changes in working capital | 521.41%1.32M | --311K | ---2.27M | 52.65%-438.52K | --1.5M | ---313K | -157.42%-926.18K | 396.40%1.61M | -183.12%-544.23K | 185.07%654.78K |
| -Change in receivables | 87.46%1.9M | ---311K | ---1.95M | -20.00%194.02K | --411.02K | --1.01M | -65.58%242.53K | 200.73%704.53K | -14.00%-699.41K | -183.04%-613.5K |
| -Change in inventory | 146.49%139K | ---117K | ---151K | -58.96%-492.23K | --39.77K | ---299K | -109.86%-309.66K | 69.76%-147.56K | -374.93%-487.98K | 143.06%177.49K |
| -Change in payables | 29.99%-719K | --739K | ---160K | 83.67%-140.31K | --1.05M | ---1.03M | -181.34%-859.05K | 64.21%1.06M | -41.04%643.16K | 874.87%1.09M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 0 | 34.51%-27.56K | 47.61%-42.08K | |||||||
| Interest received (cash flow from operating activities) | 2,460.00%384K | 367K | 391K | 103.87%218.08K | 153.08K | 15K | 49.52%106.97K | 107.07%71.54K | 122.52%34.55K | 243.82%15.53K |
| Tax refund paid | -57.53%-764K | -795K | -886K | -4.21%-2.77M | -1.03M | -485K | 20.35%-2.65M | -10.72%-3.33M | -89.80%-3.01M | -136.98%-1.59M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 73.62%4.86M | --2.92M | ---625K | -8.60%9.99M | --2.22M | --2.8M | 18.21%10.93M | -23.58%9.25M | 66.60%12.1M | 77.41%7.27M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 11.52%-668K | ---379K | ---240K | -28.22%-4.42M | ---808.3K | ---755K | 20.35%-3.45M | 11.27%-4.33M | -7.37%-4.88M | -258.24%-4.54M |
| Net investment product transactions | --0 | ---- | ---- | ---807.6K | ---53.6K | ---329K | --0 | -133.92%-413.23K | -2.14%1.22M | --1.24M |
| Dividends received (cash flow from investment activities) | 41.30%65K | --19K | --18K | 138.32%246.65K | --96.65K | --46K | 3.04%103.5K | 35.08%100.45K | 27.32%74.36K | -20.52%58.41K |
| Investing cash flow | 41.91%-603K | ---360K | ---222K | -48.98%-4.98M | ---765.25K | ---1.04M | 27.95%-3.34M | -29.47%-4.64M | -10.67%-3.58M | -171.13%-3.24M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | 91.81%-32.09K | 87.89%-391.75K | -1,996.88%-3.23M | 51.41%-154.26K |
| Net common stock issuance | ---- | ---- | ---- | --38.12M | ---- | ---- | --0 | ---- | 123.58%3.12M | --1.4M |
| Increase or decrease of lease financing | -6.26%-645K | ---644K | ---639K | -3.41%-2.45M | ---639.32K | ---607K | -110.88%-2.37M | -35.28%-1.12M | -41.09%-830.96K | -41.27%-588.96K |
| Cash dividends paid | --0 | ---- | ---- | -2.86%-4.44M | ---312 | --0 | -6.06%-4.32M | -204.62%-4.07M | -10.99%-1.34M | -9.09%-1.2M |
| Financing cash flow | -6.26%-645K | ---4.56M | ---639K | 564.79%31.23M | --37.48M | ---607K | -20.29%-6.72M | -144.92%-5.59M | -313.80%-2.28M | 70.01%-551.2K |
| Net cash flow | ||||||||||
| Beginning cash position | 323.74%47.93M | --49.92M | --51.41M | 6.11%15.16M | --12.46M | --11.31M | -6.38%14.29M | 69.20%15.26M | 62.74%9.02M | 23.74%5.54M |
| Current changes in cash | 213.10%3.61M | ---2M | ---1.49M | 4,052.30%36.25M | --38.94M | --1.15M | 189.60%872.96K | -115.61%-974.31K | 79.48%6.24M | 226.99%3.48M |
| End cash Position | 313.50%51.54M | --47.93M | --49.92M | 239.13%51.41M | --51.41M | --12.46M | 6.11%15.16M | -6.38%14.29M | 69.20%15.26M | 62.74%9.02M |
| Free cash flow | 104.70%4.18M | --2.55M | ---865K | -24.48%5.58M | --1.42M | --2.04M | 58.02%7.38M | -35.16%4.67M | 164.44%7.21M | -3.64%2.73M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.